Mike Bastian

Company: Sanofi Genzyme
Job title: Medical Manager Atopic Dermatitis
Seminars:
Dupilumab: The First Approved Biologic for Atopic Dermatitis 3:20 pm
Shining light on the rationale for biologic development during a wave of JAK inhibitor development Transforming quality of life for patients by tackling chronic itch Looking forward into bringing dupilumab into other dermatological indicationsRead more
day: Day Two